COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2008 on Friday, February 27, 2009. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Rich Hunt, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, February 27, 2009 at 9:00 a.m. ET.
